Significance of Infections in Implant Loss After Breast Reconstruction in the Course of Breast Cancer Treatment.


Journal

Polish journal of microbiology
ISSN: 2544-4646
Titre abrégé: Pol J Microbiol
Pays: Poland
ID NLM: 101229003

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 17 04 2019
revised: 14 07 2019
accepted: 14 07 2019
entrez: 28 12 2019
pubmed: 28 12 2019
medline: 15 1 2020
Statut: ppublish

Résumé

The aim of the study was to analyze the reasons for removing implants after breast reconstruction in the course of treatment of breast cancer. The study involved 428 patients, who underwent a total of 648 breast reconstruction procedures using artificial implants. 47 out of 648 cases (7.3%) were identified in which the implant had to be removed. Of the 47 cases, 57.4% had undergone deferred reconstruction, and 42.6% immediate reconstruction; 27.7% had undergone pre-operative chemotherapy and radiotherapy, 27.7% pre-operative chemotherapy, and 2.1% pre-operative radiotherapy; 6.4% were diabetic, 4.3% active smokers, and more than 50.0% had BMI greater than 25 kg/m The aim of the study was to analyze the reasons for removing implants after breast reconstruction in the course of treatment of breast cancer. The study involved 428 patients, who underwent a total of 648 breast reconstruction procedures using artificial implants. 47 out of 648 cases (7.3%) were identified in which the implant had to be removed. Of the 47 cases, 57.4% had undergone deferred reconstruction, and 42.6% immediate reconstruction; 27.7% had undergone pre-operative chemotherapy and radiotherapy, 27.7% pre-operative chemotherapy, and 2.1% pre-operative radiotherapy; 6.4% were diabetic, 4.3% active smokers, and more than 50.0% had BMI greater than 25 kg/m

Identifiants

pubmed: 31880880
doi: 10.33073/pjm-2019-037
pii: exeley
pmc: PMC7256728
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

343-351

Références

Plast Reconstr Surg. 2017 Jan;139(1):20-28
pubmed: 28027221
JAMA Surg. 2017 Sep 20;152(9):e172338
pubmed: 28724125
J Surg Oncol. 2018 Jun;117(7):1440-1446
pubmed: 29574751
Open Forum Infect Dis. 2017 Sep 02;4(4):ofx189
pubmed: 29308399
Plast Reconstr Surg. 2010 Sep;126(3):779-85
pubmed: 20811212
Infect Control Hosp Epidemiol. 2012 Feb;33(2):202-4
pubmed: 22227993
Breast. 2017 Apr;32:7-12
pubmed: 27988412
J Biomed Mater Res. 1998 Dec 5;42(3):425-32
pubmed: 9788506
Ann Plast Surg. 2013 Aug;71(2):140-3
pubmed: 23486147
Ann Plast Surg. 2016 May;76 Suppl 3:S158-61
pubmed: 27015327
Int J Infect Dis. 2015 Jun;35:62-6
pubmed: 25910855
Curr Treat Options Infect Dis. 2017 Jun;9(2):155-172
pubmed: 28959143
Ann Surg Oncol. 2014 Jan;21(1):118-24
pubmed: 24081801
Ann Plast Surg. 1993 Apr;30(4):289-95
pubmed: 8512282
Plast Reconstr Surg Glob Open. 2016 May 06;4(5):e704
pubmed: 27579229
Plast Reconstr Surg Glob Open. 2018 Dec 12;6(12):e2065
pubmed: 30656128
Ann Plast Surg. 2016 Nov;77(5):501-505
pubmed: 25003455
Plast Reconstr Surg. 2018 Nov;142(5):639e-652e
pubmed: 30096121
Plast Reconstr Surg. 2003 Apr 15;111(5):1605-11
pubmed: 12655204
Lancet Infect Dis. 2005 Feb;5(2):94-106
pubmed: 15680779
Plast Reconstr Surg. 2013 Jan;131(1):1-13
pubmed: 22965239
Ann Surg. 2016 Feb;263(2):219-27
pubmed: 25876011
Ann Plast Surg. 2007 Aug;59(2):131-6
pubmed: 17667404
Aesthetic Plast Surg. 2007 Sep-Oct;31(5):532-9
pubmed: 17659411
New Microbiol. 2018 Jul;41(3):238-241
pubmed: 29874385
Plast Reconstr Surg. 2016 Oct;138(4):751-7
pubmed: 27307337
Ann Plast Surg. 2016 Jun;76(6):629-34
pubmed: 25003437
Arch Plast Surg. 2017 Nov;44(6):516-522
pubmed: 29076316
PLoS One. 2016 Jan 26;11(1):e0146668
pubmed: 26811915
J Cancer Educ. 2017 Sep;32(3):537-542
pubmed: 26792785
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
JAMA. 2006 Jan 25;295(4):387-8
pubmed: 16434628
Arch Surg. 2010 Sep;145(9):880-5
pubmed: 20855759
Clin Microbiol Rev. 2002 Apr;15(2):167-93
pubmed: 11932229

Auteurs

Maria Szymankiewicz (M)

Department of Microbiology, Prof. F. Łukaszczyk Center of Oncology in Bydgoszcz , Poland.

Tomasz Nowikiewicz (T)

Chair and Clinic of Oncological Surgery, Ludwik Rydygier Collegium Medicum UMK in Bydgoszcz , Poland ; Clinical Department of Breast Cancer and Reconstructive Surgery, Prof. F. Łukaszczyk Center of Oncology in Bydgoszcz , Poland.

Marta Biedka (M)

Radiotherapy Department, Prof. F. Łukaszczyk Center of Oncology in Bydgoszcz , Poland ; Chair and Clinic of Oncology and Brachytherapy, Ludwik Rydygier Collegium Medicum UMK in Bydgoszcz , Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH